Leukemia & Lymphoma
Volume 63, 2022 - Issue 9
Letters to the Editor
Treatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation
Julian Lindsaya National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia;b Haematology Department, Royal North Shore Hospital, Sydney, Australia;c Vaccine and Infectious Disease and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USACorrespondence[email protected]
https://orcid.org/0000-0002-7086-538XView further author information
https://orcid.org/0000-0002-7086-538XView further author information, , , , David C. M. Kongf NHMRC National Centre for Antimicrobial Stewardship at The Peter Doherty Institute for Infections and Immunity, Parkville, Victoria, Australia;g Faculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia;h Pharmacy Department, Ballarat Health Services, Ballarat, Victoria, Australiahttps://orcid.org/0000-0002-5022-9060View further author information
https://orcid.org/0000-0002-5022-9060View further author information, Steven A. Pergamc Vaccine and Infectious Disease and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;i Division of Allergy & Infectious Diseases, University of Washington, Seattle, Washington, USAhttps://orcid.org/0000-0002-6333-5196View further author information
https://orcid.org/0000-0002-6333-5196View further author information, & Monica A. Slavina National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia;j Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia;k Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australiahttps://orcid.org/0000-0002-8443-314XView further author information
https://orcid.org/0000-0002-8443-314XView further author information show all